@article{duffy_regulatory_2021,
	title = {Regulatory action to protect access to hydroxychloroquine for approved rheumatic indications during {COVID}‐19 in {New} {Zealand}},
	issn = {2326-5191, 2326-5205},
	url = {https://onlinelibrary.wiley.com/doi/10.1002/art.41643},
	doi = {10.1002/art.41643},
	language = {en},
	urldate = {2021-04-28},
	journal = {Arthritis \& Rheumatology},
	author = {Duffy, Eamon and Arroll, Nicola and Beasley, Richard and Hills, Thomas},
	month = mar,
	year = {2021},
	pages = {art.41643},
}

{"_id":"sejxXmGhiDh9k5tvS","bibbaseid":"duffy-arroll-beasley-hills-regulatoryactiontoprotectaccesstohydroxychloroquineforapprovedrheumaticindicationsduringcovid19innewzealand-2021","author_short":["Duffy, E.","Arroll, N.","Beasley, R.","Hills, T."],"bibdata":{"bibtype":"article","type":"article","title":"Regulatory action to protect access to hydroxychloroquine for approved rheumatic indications during COVID‐19 in New Zealand","issn":"2326-5191, 2326-5205","url":"https://onlinelibrary.wiley.com/doi/10.1002/art.41643","doi":"10.1002/art.41643","language":"en","urldate":"2021-04-28","journal":"Arthritis & Rheumatology","author":[{"propositions":[],"lastnames":["Duffy"],"firstnames":["Eamon"],"suffixes":[]},{"propositions":[],"lastnames":["Arroll"],"firstnames":["Nicola"],"suffixes":[]},{"propositions":[],"lastnames":["Beasley"],"firstnames":["Richard"],"suffixes":[]},{"propositions":[],"lastnames":["Hills"],"firstnames":["Thomas"],"suffixes":[]}],"month":"March","year":"2021","pages":"art.41643","bibtex":"@article{duffy_regulatory_2021,\n\ttitle = {Regulatory action to protect access to hydroxychloroquine for approved rheumatic indications during {COVID}‐19 in {New} {Zealand}},\n\tissn = {2326-5191, 2326-5205},\n\turl = {https://onlinelibrary.wiley.com/doi/10.1002/art.41643},\n\tdoi = {10.1002/art.41643},\n\tlanguage = {en},\n\turldate = {2021-04-28},\n\tjournal = {Arthritis \\& Rheumatology},\n\tauthor = {Duffy, Eamon and Arroll, Nicola and Beasley, Richard and Hills, Thomas},\n\tmonth = mar,\n\tyear = {2021},\n\tpages = {art.41643},\n}\n\n","author_short":["Duffy, E.","Arroll, N.","Beasley, R.","Hills, T."],"key":"duffy_regulatory_2021","id":"duffy_regulatory_2021","bibbaseid":"duffy-arroll-beasley-hills-regulatoryactiontoprotectaccesstohydroxychloroquineforapprovedrheumaticindicationsduringcovid19innewzealand-2021","role":"author","urls":{"Paper":"https://onlinelibrary.wiley.com/doi/10.1002/art.41643"},"metadata":{"authorlinks":{}},"downloads":1},"bibtype":"article","biburl":"https://api.zotero.org/users/6607533/collections/NYG2RI7X/items?key=hSjrOPQRRHHWY81SKs6CEz45&format=bibtex&limit=100","dataSources":["ydy8iPhP2TsFttgY7","KWJj8zsJW4ML2G243","6SkqXiGdfnEhkfeWg","gYp5LQXkoiKhbuLwC","BvvFw2zRfGrfhQ6x4","ZJ4j4Apddh3MpQnDj"],"keywords":[],"search_terms":["regulatory","action","protect","access","hydroxychloroquine","approved","rheumatic","indications","during","covid","new","zealand","duffy","arroll","beasley","hills"],"title":"Regulatory action to protect access to hydroxychloroquine for approved rheumatic indications during COVID‐19 in New Zealand","year":2021,"downloads":1}